Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application.

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

Antiarrhythmic Drugs—Clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology

HRS Endorsed / Affirmed
Atrial Arrhythmias
Atrial Fibrillation

The Heart Rhythm Society affirmed the value of the document on August 24, 2017.

February 9, 2018—The European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology convened a Task Force, with representation from the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS), with the remit to comprehensively review the available evidence to publish a joint practical guide on antiarrhythmic drug therapy and to provide up-to-date consensus recommendations for decision making and its use in everyday clinical practice. The ultimate judgement regarding the care of a particular patient must be made by the health care provider and the patient in light of all of the circumstances presented by that patient.

2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists

Clinical EP
Training

November 27, 2017—The 2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists complements the 2015 ACC/AHA/HRS Advanced Training Statement on clinical cardiac electrophysiology by focusing on the competencies expected of practicing cardiac electrophysiologists throughout their careers. It also recognizes those competencies that exceed standard expectations and may be achieved and maintained by some cardiac electrophysiologists based on their specific training and practice focus. This document provides examples of appropriate measures for assessing competence in the context of lifelong learning.

Occupational Radiation Exposure in the Electrophysiology Laboratory with a Focus on Personnel with Reproductive Potential and During Pregnancy: 2017 EHRA Consensus Document

Clinical EP
HRS Endorsed / Affirmed

The Heart Rhythm Society endorsed the document on July 11, 2017

November 6, 2017—The purpose of this document as an adjunct to the EHRA practical guide, issued in 2014 on ways to reduce radiation dose for patients and staff during electrophysiological procedures, is to describe the current knowledge on the risks and to inform about current international recommendations and legislation on occupational exposure in the electrophysiology laboratory to personnel with childbearing potential and during pregnancy.

2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Ventricular Arrhythmias

October 30, 2017—The 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, accompanied by the Executive Summary and the Systematic Review, is intended to guide management of adults who have ventricular arrhythmias or who are at risk for sudden cardiac death (SCD), including diseases and syndromes associated with a risk of SCD from ventricular arrhythmias.

2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction

Clinical EP
Device Therapy
Pediatric

September 14, 2017—The 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction, developed in collaboration with the ACC, AHA, APHRS, ASA, EHRA, IDSA, LAHRS, PACES, and STS, is intended to help clinicians in their decision-making process for managing leads and builds on the 2009 Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Managementdocument. It provides practical clinical guidance in the broad field of lead management, including lead extraction.

2017 Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: A Joint Consensus Document from EHRA and ESC Working Group on Thrombosis

Clinical EP
HRS Endorsed / Affirmed

The Heart Rhythm Society affirmed the value of the document on June 8, 2017.

August 30, 2017—This consensus document was developed by the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Working Group on Thrombosis, with representation from the ESC Working Group on Valvular Heart Disease, Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart Association (SA Heart), and SOLAECE, and addresses management of patients with atrial fibrillation and associated valvular heart disease (VHD), with up-to-date consensus recommendations for clinical practice for different forms of VHD. 

Screening for Atrial Fibrillation: 2017 European Heart Rhythm Association (EHRA) Consensus Document

Clinical EP
HRS Endorsed / Affirmed

The Heart Rhythm Society endorsed the document on May 30, 2017.

July 5, 2017—Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. An earlier detection of AF could allow an earlier adequate management to avoid later complications. Screening for AF is not yet recommended by all scientific AF guidelines, even in specific at-risk populations. This document summarizes the available data, discusses the different strategies, and highlights the importance of implicating all stakeholders from the various health systems.

Radiation Safety in Children with Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization from the Image Gently Alliance

Pediatric
HRS Endorsed / Affirmed

The Heart Rhythm Society endorsed the document on April 4, 2017. 

May 18, 2017—The purpose of this scientific statement is to provide expert consensus recommendations for optimization of medical imaging procedures commonly performed in children with congenital and acquired heart disease (CAHD), including cardiac computed tomography, nuclear cardiology studies, and fluoroscopically guided diagnostic and interventional catheterization and electrophysiology procedures. These recommendations specifically focus on optimization approaches that, when properly implemented, will improve the radiation safety profile for children with heart disease, without compromising the diagnostic information provided by these valuable studies or other aspects of procedural safety.